| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |